Thermo Fisher Q3 revenue and EPS grow 9% and 15% respectively
Thermo Fisher Scientific reported third quarter 2026 revenue of $12.14 billion, bolstered by organic growth and innovation. The company's strong performance demonstrates the effectiveness of its growth strategy and operational execution.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed